We can highlight the next thriving fund investment areas, such as Medical, Biopharma. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Axial Biotherapeutics.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Heritage Medical Center, startups are often financed by Longwood Founders Fund, Kairos Ventures, Domain Associates. The meaningful sponsors for the fund in investment in the same round are Longwood Founders Fund, Domain Associates, Seventure Partners. In the next rounds fund is usually obtained by Taiho Ventures, Seventure Partners, Longwood Founders Fund.
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2019.
Fund Name | Location |
Agile Capital Partners | Belvedere Tiburon, California, United States |
Antin Infrastructure Partners | France, Ile-de-France, Paris |
Barrow Cadbury Trust | England, London, United Kingdom |
Bofang Hulian Touzi | China, Guangdong, Shenzhen |
Chainfund Capital | California, San Francisco, United States |
Dynamic Venture Opportunities Fund | Canada, Ontario, Toronto |
EMMA CAPITAL | Czech Republic, Prague, Prague |
Eos Funds | Saint George, South Carolina, United States |
iloom | Seoul, Seoul-t'ukpyolsi, South Korea |
Karnataka Trustee | - |
Lan Shang Capital | - |
Meaningful Partners | California, El Segundo, United States |
Niantic | California, San Francisco, United States |
Northern Venture Capital Trust | - |
Octahedron Capital | California, San Francisco, United States |
Silicon Gardens Angel Fund | - |
TackleBox | California, San Francisco, United States |
The Leeds Group | California, Costa Mesa, United States |
Weathernews | Chiba, Chiba-shi, Japan |
Yellowwoods | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Axial Biotherapeutics | $25M | 27 Feb 2019 | Massachusetts, United States | ||
Axial Biotherapeutics | $19M | 30 Nov 2016 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Axial Biotherapeutics | $25M | 27 Feb 2019 | Massachusetts, United States | ||
Axial Biotherapeutics | $19M | 30 Nov 2016 | Massachusetts, United States |